Clinical activity of single-agent gemcitabine in a single-center series of 83 malignant pleural mesothelioma after failure of pemetrexed-based chemotherapy.

e18547 Background: No standard second line chemotherapy (CT) has been yet established for Malignant Plural Mesothelioma (MPM) after failure of pemetrexed based CT. Aim of this study was to evaluate...